Literature DB >> 15004178

Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: possible role for IL-1 in herpetic stromal keratitis pathogenesis.

Partha S Biswas1, Kaustuv Banerjee, Bumseok Kim, Barry T Rouse.   

Abstract

Ocular infection with HSV may result in the blinding immunoinflammatory lesion stromal keratitis (SK). This represents a CD4+ T cell-mediated immunopathologic lesion in both humans and a mouse model. Early events in the pathogenesis that set the stage for SK are poorly understood. The present study evaluates the role of IL-1 using a transgenic mouse that overexpresses the IL-1 receptor antagonist (IL-1ra) protein. Such transgenic mice were markedly resistant to SK compared with IL-1ra(-/-) and C57BL/6 control animals. The resistance was shown to be the consequence of reduced expression of molecules such as IL-6, macrophage-inflammatory protein-2, and vascular endothelial growth factor, normally up-regulated directly or indirectly by IL-1. A critical event impaired in IL-1ra transgenic mice was vascular endothelial growth factor production with a consequent marked reduction in angiogenesis, an essential step in SK pathogenesis. Targeting IL-1 could prove to be a worthwhile therapeutic approach to control SK, an important cause of human blindness.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15004178     DOI: 10.4049/jimmunol.172.6.3736

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Local thermal injury elicits immediate dynamic behavioural responses by corneal Langerhans cells.

Authors:  Brant R Ward; James V Jester; Akiko Nishibu; Mridula Vishwanath; David Shalhevet; Tadashi Kumamoto; W Matthew Petroll; H Dwight Cavanagh; Akira Takashima
Journal:  Immunology       Date:  2007-01-22       Impact factor: 7.397

2.  Herpes simplex virus type 1 induction of chemokine production is unrelated to viral load in the cornea but not in the nervous system.

Authors:  Daniel J J Carr; Iain L Campbell
Journal:  Viral Immunol       Date:  2006       Impact factor: 2.257

Review 3.  Pathogenesis of herpes simplex keratitis: The host cell response and ocular surface sequelae to infection and inflammation.

Authors:  Ann-Marie Lobo; Alex M Agelidis; Deepak Shukla
Journal:  Ocul Surf       Date:  2018-10-11       Impact factor: 5.033

Review 4.  Herpes simplex virus and the chemokines that mediate the inflammation.

Authors:  D J J Carr; L Tomanek
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

Review 5.  Application of our understanding of pathogenesis of herpetic stromal keratitis for novel therapy.

Authors:  Naveen K Rajasagi; Barry T Rouse
Journal:  Microbes Infect       Date:  2018-01-09       Impact factor: 2.700

6.  Substance P in the corneal stroma regulates the severity of herpetic stromal keratitis lesions.

Authors:  Brandon S Twardy; Rudragouda Channappanavar; Susmit Suvas
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-04       Impact factor: 4.799

Review 7.  Corneal lymphangiogenesis in herpetic stromal keratitis.

Authors:  Paul J Park; Michael Chang; Nitin Garg; Jimmy Zhu; Jin-Hong Chang; Deepak Shukla
Journal:  Surv Ophthalmol       Date:  2014-06-10       Impact factor: 6.048

8.  Susceptibility of human iris stromal cells to herpes simplex virus 1 entry.

Authors:  John Baldwin; Paul J Park; Brian Zanotti; Erika Maus; Michael V Volin; Deepak Shukla; Vaibhav Tiwari
Journal:  J Virol       Date:  2013-01-23       Impact factor: 5.103

9.  Expression of interleukin-1 receptor antagonist in human cornea.

Authors:  Martin Heur; Shyam S Chaurasia; Steven E Wilson
Journal:  Exp Eye Res       Date:  2008-12-06       Impact factor: 3.467

Review 10.  Type I interferon and lymphangiogenesis in the HSV-1 infected cornea - are they beneficial to the host?

Authors:  Katie Bryant-Hudson; Christopher D Conrady; Daniel J J Carr
Journal:  Prog Retin Eye Res       Date:  2013-07-19       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.